[1] [1] WANG S, LI K, ZHAO T,et al. Oral tongue squamous cell carcinoma diagnosis from tissue metabolic profiling[J]. Oral Diseases, 2024, 30(4): 2158-2165.

[2] [2] SASAKI J, AOKI Y, ITO Y,et al. Squamous cell carcinoma involving the midline of the dorsum of the tongue: a case report[J]. Annals of Medicine & Surgery, 2024, 86(10): 6149-6152.

[3] [3] TIAN Q Y, JIANG L, DAI D J,et al. Impact of postoperative radiotherapy on the prognosis of early-stage (pT1-2N0M0) oral tongue squamous cell carcinoma[J]. Journal of Clinical Oncology, 2024, 42(15): 1754-1765.

[4] [4] HU D, MESSADI D V. Immune-related long non-coding RNA signatures for tongue squamous cell carcinoma[J]. Current Oncology, 2023, 30(5): 4817-4832.

[5] [5] ZHAO R M, WANG S Y, TAN L,et al. IGFL2-AS1 facilitates tongue squamous cell carcinoma progression via Wnt/-catenin signaling pathway[J]. Oral Diseases, 2023, 29(2): 469-482.

[6] [6] ZOHUD O, LONE I M, NASHEF A,et al. Towards system genetics analysis of head and neck squamous cell carcinoma using the mouse model, cellular platform, and clinical human data[J]. Animal Models and Experimental Medicine, 2023, 6(6): 537-558.

[7] [7] BARTL J, ZANINI M, BERNARDI F,et al. The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors[J]. Nature Communications, 2022, 13(1): 4061.

[8] [8] YIN X H, WANG X Y, LIU S C,et al. lncRNA HHIP-AS1/HHIP modulates osteogenic differentiation of BM-MSCs by regulating hedgehog signaling pathway[J]. Aging, 2022, 14(21): 8839-8855.

[9] [9] WU K K, WANG X W, YU H M,et al. LINC00460 facilitated tongue squamous cell carcinoma progression via the miR-320b/IGF2BP3 axis[J]. Oral Diseases, 2022, 28(6): 1496-1508.

[10] [10] YANG M, ZHANG Y M, ZHOU Y,et al. Analysis of the expression profiles of long noncoding RNAs and messenger RNAs in tongue squamous cell carcinoma[J]. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2022, 134(2): 230-239.

[11] [11] LI R, LI F L, WANG Y Z,et al. A three-long non-coding RNA signature that predicts tongue squamous cell carcinoma prognosis[J]. Oral Diseases, 2023, 29(2): 557-562.

[12] [12] ZHANG M, WU L, WANG X D,et al. lncKRT16P6 promotes tongue squamous cell carcinoma progression by sponging miR-3180 and regulating GATAD2A expression[J]. International Journal of Oncology, 2022, 61(3): 111.

[13] [13] JIA Y L, CHEN X J, ZHAO D Y,et al. SNHG1/miR-194-5p/MTFR1 axis promotes TGF1-Induced EMT, migration and invasion of tongue squamous cell carcinoma cells[J]. Molecular Biotechnology, 2022, 64(7): 780-790.

[14] [14] BO C W, LI X L, HE L,et al. A novel long noncoding RNA HHIP-AS1 suppresses hepatocellular carcinoma progression through stabilizing HHIP mRNA[J]. Biochemical and Biophysical Research Communications, 2019, 520(2): 333-340.

[15] [15] YANG Y, CHENG Y, MOU Y F,et al. Natural antisense long noncoding RNA HHIP-AS1 suppresses non-small-cell lung cancer progression by increasing HHIP stability via interaction with CELF2[J]. Critical Reviews in Eukaryotic Gene Expression, 2022, 33(1): 67-77.

[16] [16] YADAV A, BISWAS T, PRAVEEN A,et al. Targeting MALAT1 augments sensitivity to PARP inhibition by impairing homologous recombination in prostate cancer[J]. Cancer Research Communications, 2023, 3(10): 2044-2061.

[17] [17] YANG S, GUAN H, CHEN Z J,et al. LncRNA HOXA11-AS modulates the miR-148b-3p/MLPH axis to promote prostate cancer cell proliferation[J]. Cellular and Molecular Biology (Noisy-le-Grand, France), 2023, 69(3): 92-97.

[18] [18] YOU P H, TANG L Y, ZHU Y J,et al. Brevilin a shows an anti-tumor role in prostate cancer via the lncRNA H19/miR-194/E2F3 signaling pathway[J]. Aging, 2023, 15(10): 4411-4428.

[19] [19] WU C G, CHEN J, WANG D. LncRNA VPS9D1-AS1 regulates miR-187-3p/fibroblast growth factor receptor-like 1 axis to promote proliferation, migration, and invasion of prostate cancer cells[J]. The Chinese Journal of Physiology, 2023, 66(5): 295-305.

[20] [20] DU L J, DOU K K, ZHANG D,et al. miR-19a-3p promotes aerobic glycolysis in ovarian cancer cells via IGFBP3/PI3K/AKT pathway[J]. Folia Biologica, 2023, 69(5/6): 163-172.

[21] [21] PENG T, YANG F, SUN Z W,et al. miR-19a-3p facilitates lung adenocarcinoma cell phenotypes by inhibiting TEK[J]. Cancer Biotherapy and Radiopharmaceuticals, 2022, 37(7): 589-601.

[22] [22] XIANG Y, LIU H, HU H,et al. LINC00094/miR-19a-3p/CYP19A1 axis affects the sensitivity of ER positive breast cancer cells to letrozole through EMT pathway[J]. Aging, 2022, 14(11): 4755-4768.

[23] [23] YE C Y, LIN Q B, ZHENG C P. Overexpressed RBPMS-AS1 increased cell radiosensitivity by sponging miR-19a-3p in lung cancer cell lines (A549 and SK-MES-1) via regulating PTEN/AKT axis[J]. International Journal of Radiation Biology, 2023, 99(9): 1352-1363.

[24] [24] LI D, LIU K, LI Z Y,et al. miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells[J]. Cell Adhesion & Migration, 2018, 12(3): 236-246.